Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Seelos Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 36 | 23 | −13 |
| Shares | 2.63M | 213.5K | −2.41M (−91.9%) |
| Value | $1.55M | $129.4K | −$1.42M (−91.7%) |
New holders (1)
Institutions that held Seelos Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TD Waterhouse Canada Inc. | 8 | $5 | 0.00% |
Sold out (14)
Institutions that held Seelos Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Gendell Jeffrey L | 428,966 | $253.5K |
| Balyasny Asset Management LLC | 379,239 | $224.1K |
| Vanguard Group Inc | 280,866 | $166.0K |
| Strategic Family Wealth Counselors, L.L.C. | 30,010 | $17.7K |
| Jane Street Group, LLC | 23,009 | $13.6K |
| XTX Topco Ltd | 16,071 | $9.50K |
| Two Sigma Investments, LP | 13,085 | $7.73K |
| State Street Corp | 12,948 | $7.65K |
| CRA Financial Services, LLC | 11,889 | $7.03K |
| Wealth Enhancement Advisory Services, LLC | 10,018 | $5.92K |
| Advisor Group Holdings, Inc. | 8,233 | $4.76K |
| First Manhattan Co | 372 | $219 |
| Aspire Private Capital, LLC | 50 | $30 |
| TSFG, LLC | 3 | $0 |